PROGRAM NASIONAL UNTUK ELIMINASI FILARIASIS LIMFATIK: STUDI KASUS DI KABUPATEN PEKALONGAN, JAWA TENGAH
Keywords:
lymphatic filariasis, MDA, Pekalongan Regency, Vector
Abstract
Programmes to eliminate lymphatic filariasis are underway in all provinces of Indonesia. Central Java is big ten chronic case of Lymphatic Filariasis (LF) from 34 provinces in Indonesia. Started in 2015, Ministry of Health Republic Indonesia launched filariasis elimination by implementing preventive mass drug administration (MDA) or “POPM”. At least as 65% of the population in the district/city are given diethylcarbamazine citrate (DEC) and albendazole. This study aims to determine the constraints and problems encountered in the MDA implementation and the steps toward filariasis elimination. The method applied is a review of the scientific article, policy inventory, discussions with experts and practitioners, as well as field data confirmation. This study result describes of MDA coverage in Pekalongan Regency above of minimal coverage 65%, and around three years subsequently reaching 80%, the occurrence of side reactions after consuming drugs lower than 1% from all population target. This study noted that MDA implementation in Pekalongan District has fulfilled the target. However, program evaluation not only tablet distribution, but also data of compliance with taking medication. Conclusion of this study is that MDA must also be supported by vector control and completion through molecular examination as an assessment of mosquito capacity as a vector of lymphatic filariasis.
References
Alexander NDE, 2015. Are We Nearly There Yet? Coverage and Compliance of Mass Drug Administration for Lymphatic Filariasis Elimination. Trans R Soc Trop Med Hyg, 109(March), pp.173–174.
Anorital, Marleta R & Palupi K, 2016. Studi kajian Upaya Pemberian Obat Pencegah Masal Filariasis Terhadap Pengendalian Penyakit Infeksi Kecacingan. Jurnal Biotek Medisiana Indonesia, 5(2), pp.95–103.
Appawu MA, Dadzie SK, Baffoe-wilmot A & Wilson MD, 2001. Lymphatic filariasis in Ghana : Entomological Investigation of Transmission Dynamics and Intensity in Communities Served by Irrigation Systems in the Upper East Region of Ghana. Tropical medicine & international health : TM & IH, 6(7), pp.511–516.
Cano J, Rebollo MP, Golding N, Pullan RL, Crellen T, Soler A, et al., 2014. The Global Distribution and Transmission Limits of Lymphatic Filariasis : Past and Present. BioMed Central, 7(466), pp.1–19.
Chandy A, Thakur AS, Singh MP & Manigauha A, 2011. A Review of Neglected Tropical Diseases : Filariasis. Asian Pacific Journal of Tropical Medicine, 4(7), pp.581–586.
Erlan A, 2014. Promosi Kesehatan dalam Pengendalian Filariasis. Balaba, 10(02), pp.89–96.
Goldman AS, Guisinger VH, Aikins M, Amarillo MLE, Vicente Y, Garshong B, et al., 2007. National Mass Drug Administration Costs for Lymphatic Filariasis Elimination. 1(1).
Hussain MA, Sitha AK, Swain S, Kadam S & Pati S, 2014. Mass Drug Administration for Lymphatic Filariasis Elimination in a Coastal State of India : A Study on Barriers to Coverage and Compliance. Infectious Diseases of Proverty, 3(1), pp.1–8.
Ichimori K, King JD, Engels D, Yajima A, Mikhailov A, Lammie P, et al., 2014. Global Programme to Eliminate Lymphatic Filariasis : The Processes Underlying Programme Success. Plos Neglected Tropical Duseases, 8(12), pp.1–9.
Ipa M, Astuti EP, Hakim L & Fuadzy H, 2016. Analisis Cakupan Obat Massal Pencegahan Filariasis di Kabupaten Bandung dengan Pendekatan Model Sistem Dinamik. Balaba, 12(1), pp.31–38.
Kemenkes RI, 2016. Permenkes No 94 Tahun 2014, Indonesia.
Moeloek NF, Demak B, Natsir M, Gajah K, Demak K & Semarang K, 2018. Menkes : Ayo Wujudkan Keluarga Indonesia Yang Bebas Kaki Gajah,
Ramaiah KD & Ottesen EA, 2014. Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease. Plos Neglected Tropical Duseases, 8(11), pp.1–10.
Rao RU, Nagodavithana KC, Samarasekera SD, Miller JP & Weil GJ, 2014. A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years After Cessation of Mass Drug Administration. Plos Neglected Tropical Duseases, 8(11), pp.1–13.
Rosanti TI & Azis A, 2015. Deskripsi Alasan Ketidakpatuhan Minum Obat pada Program Pemberian Obat Massal Pencegahan (POMP) Filaria Tahun 2015 di Kelurahan Pabean Pekalongan Utara Kota Pekalongan. Mandala of Health, 8(September), pp.642–645.
Santoso, Saikhu A, Taviv Y, Yuliani R, Mayasari R & Supardi, 2010. Community Compliance to Filarial Mass Drug Administration in Belitung Timur Regency 2008. Buletin Penelitian Kesehatan, 38(4), pp.185–197.
Santoso, Yenni A, Oktarina R & Wurisastuti T, 2015. Effectiveness of Two Rounds of Mass Drug Administration Using DEC Combined with Albendazole on the Prevalence of Brugia malayi. Buletin Penelitian Kesehatan, 18(2), pp.161–168.
Simonsen PE & Mwakitalu ME, 2013. Urban Lymphatic Filariasis. Parasitol Res, 112(1), pp.35–44.
Sodahlon YK, Dorkenoo AM, Morgah K, Nabiliou K, Agbo K, Miller R, et al., 2013. A Success Story : Togo is Moving Toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis Through Mass Drug Administration and Countrywide Morbidity Alleviation. Plos Neglected Tropical Duseases, 7(4), pp.1–8.
Stolk WA, Bosch QA, Vlas SJ De, Fischer PU & Weil GJ, 2013. Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis. Plos Neglected Tropical Duseases, 7(1), pp.1–13.
Stone CM, Lindsay SW & Chitnis N, 2014. How Effective is Integrated Vector Management Against Malaria and Lymphatic Filariasis Where The Diseases are Transmitted by the Same Vector? Plos Neglected Tropical Duseases, 8(12), pp.1–15.
Tri Ramadhani BY, 2009. Aktivitas Menggigit Nyamuk Culex quinquefasciatus di Daerah Endemis Filariasis Limfatik Kelurahan Pabean Kota Pekalongan Provinsi Jawa Tengah. Aspirator, 1(1), pp.11–15.
Weerasooriya M V., Yahathugoda CT, Wickramasinghe D, Gunawardena KN, Dharmadasa RA, Vidanapathirana KK, et al., 2007. Social Mobilisation, Drug Coverage and Compliance and Adverse Reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. Filaria Journal, 6(11), pp.1–10.
Welburn SC, Beange I, Ducrotoy MJ & Okello AL, 2015. The Neglected Zoonoses - the Case for Integrated Control and Advocacy. Clinical Microbiology and Infection, 21(5), pp.433–443.
WHO, 2009. World Health Organiztion Global Programe to Eliminate Lymphatic Filariasis,
Yanuarini C, Aisah S & Maryam, 2015. Faktor-faktor yang Berhubungan dengan Kejadian Filariasis di Puskesmas Tirto I Kabupaten Pekalongan. Fikkes Jurnal Keperawatan, 8(1), pp.1–14.
Yudianto K, Saraswati LD & Ginanndjar P, 2017. Faktor Risiko Kejadian Filariasis di Kecamatan Tirto Kabupaten Pekalongan. Jurnal Kesehatan Masyarakat, 5 (vol. 5, no 4), pp.396–408.
Anorital, Marleta R & Palupi K, 2016. Studi kajian Upaya Pemberian Obat Pencegah Masal Filariasis Terhadap Pengendalian Penyakit Infeksi Kecacingan. Jurnal Biotek Medisiana Indonesia, 5(2), pp.95–103.
Appawu MA, Dadzie SK, Baffoe-wilmot A & Wilson MD, 2001. Lymphatic filariasis in Ghana : Entomological Investigation of Transmission Dynamics and Intensity in Communities Served by Irrigation Systems in the Upper East Region of Ghana. Tropical medicine & international health : TM & IH, 6(7), pp.511–516.
Cano J, Rebollo MP, Golding N, Pullan RL, Crellen T, Soler A, et al., 2014. The Global Distribution and Transmission Limits of Lymphatic Filariasis : Past and Present. BioMed Central, 7(466), pp.1–19.
Chandy A, Thakur AS, Singh MP & Manigauha A, 2011. A Review of Neglected Tropical Diseases : Filariasis. Asian Pacific Journal of Tropical Medicine, 4(7), pp.581–586.
Erlan A, 2014. Promosi Kesehatan dalam Pengendalian Filariasis. Balaba, 10(02), pp.89–96.
Goldman AS, Guisinger VH, Aikins M, Amarillo MLE, Vicente Y, Garshong B, et al., 2007. National Mass Drug Administration Costs for Lymphatic Filariasis Elimination. 1(1).
Hussain MA, Sitha AK, Swain S, Kadam S & Pati S, 2014. Mass Drug Administration for Lymphatic Filariasis Elimination in a Coastal State of India : A Study on Barriers to Coverage and Compliance. Infectious Diseases of Proverty, 3(1), pp.1–8.
Ichimori K, King JD, Engels D, Yajima A, Mikhailov A, Lammie P, et al., 2014. Global Programme to Eliminate Lymphatic Filariasis : The Processes Underlying Programme Success. Plos Neglected Tropical Duseases, 8(12), pp.1–9.
Ipa M, Astuti EP, Hakim L & Fuadzy H, 2016. Analisis Cakupan Obat Massal Pencegahan Filariasis di Kabupaten Bandung dengan Pendekatan Model Sistem Dinamik. Balaba, 12(1), pp.31–38.
Kemenkes RI, 2016. Permenkes No 94 Tahun 2014, Indonesia.
Moeloek NF, Demak B, Natsir M, Gajah K, Demak K & Semarang K, 2018. Menkes : Ayo Wujudkan Keluarga Indonesia Yang Bebas Kaki Gajah,
Ramaiah KD & Ottesen EA, 2014. Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease. Plos Neglected Tropical Duseases, 8(11), pp.1–10.
Rao RU, Nagodavithana KC, Samarasekera SD, Miller JP & Weil GJ, 2014. A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years After Cessation of Mass Drug Administration. Plos Neglected Tropical Duseases, 8(11), pp.1–13.
Rosanti TI & Azis A, 2015. Deskripsi Alasan Ketidakpatuhan Minum Obat pada Program Pemberian Obat Massal Pencegahan (POMP) Filaria Tahun 2015 di Kelurahan Pabean Pekalongan Utara Kota Pekalongan. Mandala of Health, 8(September), pp.642–645.
Santoso, Saikhu A, Taviv Y, Yuliani R, Mayasari R & Supardi, 2010. Community Compliance to Filarial Mass Drug Administration in Belitung Timur Regency 2008. Buletin Penelitian Kesehatan, 38(4), pp.185–197.
Santoso, Yenni A, Oktarina R & Wurisastuti T, 2015. Effectiveness of Two Rounds of Mass Drug Administration Using DEC Combined with Albendazole on the Prevalence of Brugia malayi. Buletin Penelitian Kesehatan, 18(2), pp.161–168.
Simonsen PE & Mwakitalu ME, 2013. Urban Lymphatic Filariasis. Parasitol Res, 112(1), pp.35–44.
Sodahlon YK, Dorkenoo AM, Morgah K, Nabiliou K, Agbo K, Miller R, et al., 2013. A Success Story : Togo is Moving Toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis Through Mass Drug Administration and Countrywide Morbidity Alleviation. Plos Neglected Tropical Duseases, 7(4), pp.1–8.
Stolk WA, Bosch QA, Vlas SJ De, Fischer PU & Weil GJ, 2013. Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis. Plos Neglected Tropical Duseases, 7(1), pp.1–13.
Stone CM, Lindsay SW & Chitnis N, 2014. How Effective is Integrated Vector Management Against Malaria and Lymphatic Filariasis Where The Diseases are Transmitted by the Same Vector? Plos Neglected Tropical Duseases, 8(12), pp.1–15.
Tri Ramadhani BY, 2009. Aktivitas Menggigit Nyamuk Culex quinquefasciatus di Daerah Endemis Filariasis Limfatik Kelurahan Pabean Kota Pekalongan Provinsi Jawa Tengah. Aspirator, 1(1), pp.11–15.
Weerasooriya M V., Yahathugoda CT, Wickramasinghe D, Gunawardena KN, Dharmadasa RA, Vidanapathirana KK, et al., 2007. Social Mobilisation, Drug Coverage and Compliance and Adverse Reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. Filaria Journal, 6(11), pp.1–10.
Welburn SC, Beange I, Ducrotoy MJ & Okello AL, 2015. The Neglected Zoonoses - the Case for Integrated Control and Advocacy. Clinical Microbiology and Infection, 21(5), pp.433–443.
WHO, 2009. World Health Organiztion Global Programe to Eliminate Lymphatic Filariasis,
Yanuarini C, Aisah S & Maryam, 2015. Faktor-faktor yang Berhubungan dengan Kejadian Filariasis di Puskesmas Tirto I Kabupaten Pekalongan. Fikkes Jurnal Keperawatan, 8(1), pp.1–14.
Yudianto K, Saraswati LD & Ginanndjar P, 2017. Faktor Risiko Kejadian Filariasis di Kecamatan Tirto Kabupaten Pekalongan. Jurnal Kesehatan Masyarakat, 5 (vol. 5, no 4), pp.396–408.
Published
2018-10-31
How to Cite
Irawan, A., Boesri, H., Nugroho, S., & Nugroho, S. (2018). PROGRAM NASIONAL UNTUK ELIMINASI FILARIASIS LIMFATIK: STUDI KASUS DI KABUPATEN PEKALONGAN, JAWA TENGAH. Vektora : Jurnal Vektor Dan Reservoir Penyakit, 10(2), 95-102. https://doi.org/10.22435/vk.v10i2.1057
Section
Articles
